ilomastat has been researched along with trinitrobenzenesulfonic acid in 1 studies
| Studies (ilomastat) | Trials (ilomastat) | Recent Studies (post-2010) (ilomastat) | Studies (trinitrobenzenesulfonic acid) | Trials (trinitrobenzenesulfonic acid) | Recent Studies (post-2010) (trinitrobenzenesulfonic acid) |
|---|---|---|---|---|---|
| 103 | 0 | 45 | 2,710 | 10 | 1,042 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, W; Wang, YD | 1 |
1 other study(ies) available for ilomastat and trinitrobenzenesulfonic acid
| Article | Year |
|---|---|
Protective effect of ilomastat on trinitrobenzenesulfonic acid-induced ulcerative colitis in rats.
Topics: Animals; Anti-Inflammatory Agents; Colitis, Ulcerative; Colon; Disease Models, Animal; Dose-Response Relationship, Drug; Gastrointestinal Agents; Hydroxamic Acids; Immunohistochemistry; Indoles; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase Inhibitors; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-1; Trinitrobenzenesulfonic Acid | 2008 |